Sponsors (8)
The bill creates a supervised pathway for Americans to import certain prescription drugs from certified Canadian pharmacies to lower out‑of‑pocket costs, but its benefits are limited by exclusions, a narrow supplier pool, reliance on timely FDA rulemaking, and added administrative costs.
People who pay high drug prices (including uninsured patients and many with chronic conditions) can legally import up to a 90‑day supply of certain prescription drugs from certified Canadian pharmacies, lowering out‑of‑pocket costs for those medicines.
Patients with chronic conditions gain a safety‑screened import option because participating pharmacies must meet quality‑assurance, lab testing, and grievance procedures before listing.
Patients (including Medicare beneficiaries) get clearer regulatory direction because the FDA must issue implementing regulations and publish an approved‑pharmacy list within 180 days, creating a supervised pathway for imports.
Many commonly needed or high‑cost medicines (for example, biologics and many infused or refrigerated drugs) are ineligible for importation, so large groups of patients will not benefit from this program.
The limited supplier pool (e.g., requirements like a 5‑year existence and other criteria) could restrict drug availability and competition, keeping prices higher than expected for some medicines.
Access depends on timely and sufficiently broad FDA rulemaking within the statutory 180‑day window; delays or narrow implementing regulations could prevent patients from getting prompt access to imports.
Based on analysis of 2 sections of legislative text.
Allows individuals to import up to a 90‑day supply of certain FDA‑equivalent prescription drugs from FDA‑certified Canadian pharmacies after FDA rulemaking.
Introduced February 19, 2025 by Amy Klobuchar · Last progress February 19, 2025
Allows U.S. individuals to import certain prescription drugs from FDA‑certified pharmacies physically located in Canada for personal use (up to a 90‑day supply). The FDA must issue implementing regulations within 180 days and publish a certified list of Canadian pharmacies that meet specified safety, quality, and operational criteria; many drug categories (e.g., controlled substances, biologics, refrigerated or IV drugs) are excluded.